Thirteen years ago, Labroots launched a new learning platform for a global scientific audience. This year, the 13th Annual Event in the Clinical Diagnostics & Research Virtual Event Series will again bring together clinicians, researchers, medical experts, and professionals to discuss the latest advances in the field. As always, Labroots aims to elevate the level of collaboration and in turn, advance clinical diagnostics, research and medicine.
On November 9, 2022, thousands will join in a discussion of the continuous progress made with advances in laboratory testing, patient care, and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices.
Call for Posters — Do you work in clinical research or diagnostics? Share your research with a virtual poster! Virtual poster sessions offer the opportunity to present your data to a global audience via a PDF poster with optional video summary and discuss the results with interested colleagues across the globe through email or our virtual networking lounge. Plan now to have your poster included in the 2022 Clinical Research & Diagnostics Virtual Event. Read about how to optimize your poster for a virtual audience here.
Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global clinical research community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education - Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Connect with us!
When you attend the event remember to use the hashtag #LRclinical to follow the conversation and connect with other members of the global Clinical & Molecular Dx community!
Follow @Diagnostics_LR on Twitter and @ClinicalandMolecularDiagnostics.LR on Facebook to connect with our specialist Clinical & Molecular Dx Writers and stay up to date with the latest Trending News in Clinical & Molecular Dx.
Now, you can also join our Clinical & Molecular Dx Interest Group on LinkedIn to connect with us, and the wider professional community!
Senior Director of Assay Development, Fortis Life Sciences
Managing Director, Health Catalysts Group and Professor of Practice, Biomedical Diagnostics, Arizona State University
Professor of Infectious Diseases, School of Medicine, at UFBA
Lecturer, Biomedical Diagnostics, Arizona State University
Founder and Director of HIV Survivors and Partners Network (HSPN)
Applications Scientist, Thermo Fisher Scientific
Scientist, CloudLIMS.com
Staff Clinical Biochemist, Sunnybrook Health Sciences Center (SHSC)
Executive Director Joint Clinical Research Centre
Associate Director and Head of the Prevention and Community Directorate
Senior Manager, Product Applications, Thermo Fisher Scientific
Field Application Specialist NextGenPCR, Molecular Biology Systems
Founder and Principal, Medical Laboratory Strategy and Leadership, LLC
Assistant Professor and Medical Director, Clinical Chemistry and Toxicology, University of Utah/ARUP Laboratories
Clinical Chemist, Director, Clinical Chemistry Section, Department of Pathology and Laboratory Medicine, Penn Medicine Lancaster General Hospital
Acutis Diagnostics, Senior Scientist
Sr. Applications Scientist, Thermo Fisher Scientific
Clinical Biochemist, Mount Sinai Hospital, Pathology & Laboratory Medicine, Assistant Professor, University of Toronto, Laboratory Medicine and Pathobiology, Co-Lead, GENCOV - Covid-19 Prospective Clinical Research Study
R&D Leader, Capillary Electrophoresis - Thermo Fisher Scientific
Founder, inGENEious Rx
Co-founder & Chief Science Officer - Hyrax Biosciences
Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...
See moreABSA International (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. Its goals are to provide a professional association that represents the interests and needs of practitioners ...
See moreFor over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...
See moreDiasorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics.
Fortis Life Sciences is a strategic platform providing capital, expertise, and operational resources enabling the growth and success of founder-led life sciences tools companies. Fortis Life Sciences was founded in 2020, with the vision of creating an exceptional life sciences ...
See moreThermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving ...
See moreThe speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Suzie Alarcon CGMBS, MB(ASCP)CM is the manager of the Next Generation Sequencing Core at the La Jolla Institute for Immunology (LJI) and Team Leader of Team LJI - winner of the XPRIZE Rapid COVID Testing competition. Suzie has 18 years of experience working in molecular biology ...
See moreBrian McNally, PhD is a Vice President at Kx Advisors and is based in Washington, DC. Brian brings his deep expertise in diagnostics and life sciences to create tailored growth strategies for his clients. He specializes in corporate strategy, product development, market sizing ...
See moreDr. Paul Yip is Division Head of Clinical Biochemistry at Sunnybrook Health Sciences Center in Toronto, and is Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Prior to his current position, he was at University Health ...
See more